Global Blood Glucose Monitors Market Research Report 2022

Due to the COVID-19 pandemic, the global Blood Glucose Monitors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Blood Glucose Monitors market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Blood Glucose Monitors landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Blood Glucose Test Strips accounting for % of the Blood Glucose Monitors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Family segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Blood Glucose Monitors include Roche, LifeScan, Abbott, Ascensia, ARKRAY, I-SENS, Omron, B. Braun and 77 Elektronika, etc. In terms of revenue, the global 3 largest players have a % market share of Blood Glucose Monitors in 2021.
This report focuses on Blood Glucose Monitors volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Blood Glucose Monitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Blood Glucose Monitors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Blood Glucose Test Strips
Blood Glucose Meter
Segment by Application
Family
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Sinocare
Yicheng
Yuwell
Acon